📋 Tender Overview
Amendola Communications a nationally recognized award-winning healthcare and technology public relations and marketing agency announced today that infectious disease testing technology leader Alveo Technologies has chosen the firm as its public relations agency to manage thought leadership initiatives media relations content marketing and social media.Alveo is leading the transformation of the consumer health tech market with a low-cost easy-to-use diagnostic platform that will change the way infectious diseases are detected and managed. With an initial focus on acute respiratory infections including COVID-19 Influenza AB and RSV Alveos agile and dynamic be. well diagnostic platform can be adapted to detect a wide range of diseases that threaten public health.Creating greater accessibility to rapid accurate easy-to-use infectious disease testing is a key step to managing COVID-19 said Ron Chiarello founder and CEO Alveo Technologies. We are excited to more broadly share the story of how our be.well diagnostic testing platform can contribute to this important global initiative and look forward to collaborating with Amendola to amplify our message.Amendola is excited to be partnering with Alveo right before their be.well COVID-19 Test is poised to begin commercialization said Jodi Amendola agency CEO. We look forward to helping raise awareness of how Alveo is leading the transformation of the consumer health tech market with a low-cost easy-to-use diagnostic platform that will change the way infectious diseases are detected and managed.
